Safety and Efficacy of Cryoablation for Metastatic Lung Tumors
- Conditions
- Metastatic Lung Cancer
- Interventions
- Device: Cryoablation
- First Posted Date
- 2011-03-03
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01307501
- Locations
- 🇺🇸
Ronald Regan UCLA Medical Center, Los Angeles, California, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Mayo Clinic Rochester, Rochester, Minnesota, United States
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
- Conditions
- Heart Failure
- Interventions
- Device: MADIT-CRT ICDDevice: MADIT-CRT CRT-D
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 394
- Registration Number
- NCT01294449
- Locations
- 🇺🇸
University of Rochester /Strong Memorial, Rochester, New York, United States
SuperNOVA Clinical Stenting Trial
- Conditions
- Atherosclerosis of Native Arteries of the Extremities, Unspecified
- Interventions
- Device: Stent implantation
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 299
- Registration Number
- NCT01292928
- Locations
- 🇺🇸
Medical Center East, Birminham, Alabama, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸St. Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
- Conditions
- AtherosclerosisCoronary Artery Disease
- Interventions
- Device: TAXUS Liberté Coronary Stent SystemDevice: PROMUS Element Coronary Stent System
- First Posted Date
- 2011-01-31
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT01285999
- Locations
- 🇨🇳
Cardiovascular Institute and Fu Wai Hospital, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, China
🇨🇳Peking University First Hospital, Beijing, China
Restoration of Atrioventricular Synchrony Trial
- Conditions
- First Degree AV Block
- Interventions
- Device: Cardiac resynchronization therapy-defibrillator
- First Posted Date
- 2011-01-12
- Last Posted Date
- 2017-06-26
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 2
- Registration Number
- NCT01275833
The Jetstream G3™ Calcium Study
- Conditions
- Peripheral Arterial Disease
- Interventions
- Device: Jetstream Atherectomy System
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 55
- Registration Number
- NCT01273623
- Locations
- 🇺🇸
Arizona Heart Institute, Phoenix, Arizona, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸St. John Hopital, Detroit, Michigan, United States
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
- Conditions
- Atrial Flutter
- Interventions
- Device: Blazer® Open-Irrigated Ablation CatheterDevice: Control Catheter
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 302
- Registration Number
- NCT01253200
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸St. Jude Medical Center, Fullerton, California, United States
🇺🇸Regional Cardiology Associates, Sacramento, California, United States
Study of Cytrix Use in Pelvic Floor Prolapse Treatment
- Conditions
- Vaginal Vault Prolapse
- Interventions
- Device: CytrixOther: Other treatments for pelvic organ prolapse
- First Posted Date
- 2010-11-19
- Last Posted Date
- 2010-11-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 45
- Registration Number
- NCT01244165
TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)
- Conditions
- Coronary Heart Disease
- Interventions
- Procedure: Coronary artery stenting
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1014
- Registration Number
- NCT01242696
- Locations
- 🇧🇪
Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium
🇧🇪CHU de Charleroi - ISPPC, Charleroi, Belgium
🇧🇪H-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium
Evaluation of Left Ventricular Autothreshold, Phase Two
- Conditions
- Heart Failure
- Interventions
- Device: CRT-D
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2012-10-03
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01242722
- Locations
- 🇺🇸
Regional Cardiovascular Medical Center, Stuebenville, Ohio, United States